MapLight Therapeutics, Inc.
MPLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001770069
In the last 90 days, MapLight Therapeutics, Inc. insiders filed 3 open-market purchases and 8 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $941.0M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding MapLight Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 81 | +8 |
| Shares | 23.1M | 869.7K | 24.7M | +2.50M (+11.3%) |
| Value | $405.1M | $15.3M | $502.2M | +$112.3M (+28.8%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held MapLight Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 719,820 | $14.6M | 0.00% |
| ADAR1 Capital Management, LLC | 374,909 | $7.62M | 0.46% |
| Ra Capital Management, L.P. | 248,294 | $5.05M | 0.05% |
| Superstring Capital Management LP | 192,139 | $3.91M | 2.79% |
| Vanguard Fiduciary Trust Co | 131,231 | $2.67M | 0.00% |
| Price T Rowe Associates Inc | 112,708 | $2.29M | 0.00% |
| Vanguard Portfolio Management LLC | 112,604 | $2.29M | 0.00% |
| Janus Henderson Group PLC | 54,752 | $1.11M | 0.00% |
| Wellington Management Group LLP | 46,208 | $939.4K | 0.00% |
| Market Street Wealth Management Advisors LLC | 14,124 | $287.1K | 0.05% |
| Two Sigma Investments, LP | 14,098 | $286.6K | 0.00% |
| XTX Topco Ltd | 10,261 | $208.6K | 0.00% |
| Vanguard Global Advisers, LLC | 8,428 | $171.3K | 0.00% |
| GAMMA Investing LLC | 94 | $1.91K | 0.00% |
| CWM, LLC | 57 | $1.16K | 0.00% |
| Versant Capital Management, Inc | 50 | $1.02K | 0.00% |
| Root Financial Partners, LLC | 28 | $569 | 0.00% |
| MAI Capital Management | 12 | $244 | 0.00% |
| Allworth Financial LP | 6 | $122 | 0.00% |
| EverSource Wealth Advisors, LLC | 6 | $122 | 0.00% |
| True Wealth Design, LLC | 3 | $61 | 0.00% |
| SRS Capital Advisors, Inc. | 5 | $20 | 0.00% |
Sold out (14)
Institutions that held MapLight Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Perceptive Advisors LLC | 550,000 | $9.66M |
| Jain Global LLC | 327,693 | $5.76M |
| Citadel Advisors LLC | 190,139 | $3.34M |
| Ameriprise Financial Inc | 66,872 | $1.17M |
| Diadema Partners LP | 63,791 | $1.12M |
| OrbiMed Advisors LLC | 56,000 | $952.0K |
| Marshall Wace, LLP | 39,659 | $696.8K |
| Persistent Asset Partners Ltd | 21,766 | $382.3K |
| Oxford Asset Management LLP | 17,763 | $312.0K |
| Millennium Management LLC | 13,945 | $244.9K |
| Lynx1 Capital Management LP | 13,477 | $236.7K |
| Royal Bank of Canada | 582 | $10.0K |
| Amalgamated Bank | 530 | $9.00K |
| Federation des caisses Desjardins du Quebec | 500 | $8.78K |
Not filed for Q1 2026 yet (1)
Institutions that held MapLight Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 869,668 | $15.3M |